Hims & Hers Health (MEX:HIMS) Tax Provision: MXN458 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:HIMS Hims & Hers Health Inc MEX:HIMS
58 GF Score
Price MXN589.24
GF Value MXN692.64
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Hims & Hers Health Tax Provision?

Hims & Hers Health MEX:HIMS -8.64% 58 Tax Provision is MXN458 Mil as of Mar. 2026. GuruFocus rates MEX:HIMS with a GF Score™ of 58/100 and a GF Value™ of MXN692.64 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Hims & Hers Health's tax provision for the three months ended in Mar. 2026 was MXN170 Mil. Its tax provision for the trailing twelve months (TTM) ended in Mar. 2026 was MXN458 Mil.

Hims & Hers Health Tax Provision Historical Data

* Premium members only.

The historical data trend for Hims & Hers Health's Tax Provision can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hims & Hers Health Tax Provision Chart

Hims & Hers Health Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Tax Provision
Get a 7-Day Free Trial 64.33 0.60 -33.52 1,133.03 79.96

Hims & Hers Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Tax Provision Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -225.25 181.74 65.14 40.48 170.16
MEX:HIMS
58GF Score
Hims & Hers Health Inc MEX:HIMS
Tax Provision is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hims & Hers Health Tax Provision Calculation

Tax to be paid.

Tax Provision for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN458 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Tax Provision →
What does a Tax Provision of MXN458 Mil mean?
Hims & Hers Health (MEX:HIMS) has a Tax Provision of MXN458 Mil as of Mar. 2026. Provision for taxes is the amount of tax the company owes based on pre-tax income. View historical data on Hims & Hers Health and its competitors.
Is Hims & Hers Health's Tax Provision too high?
Hims & Hers Health's current Tax Provision is MXN458 Mil. Overall, Hims & Hers Health has a GF Score™ of 58/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Hims & Hers Health's Tax Provision compare to LNTH and LQDA?
Hims & Hers Health's Tax Provision of MXN458 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tax Provision for a Drug Manufacturers company?
A good Tax Provision depends on the Drug Manufacturers industry context. However, Tax Provision should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tax Provision mean?
A high Tax Provision can signal that a stock is expensive relative to its fundamentals. Provision for taxes is the amount of tax the company owes based on pre-tax income. View historical data on Hims & Hers Health and its competitors. Hims & Hers Health's current Tax Provision is MXN458 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hims & Hers Health stock overvalued right now?
Based on GuruFocus' analysis, Hims & Hers Health (MEX:HIMS) is currently considered Modestly Undervalued. The stock's GF Value™ is MXN692.64, compared to a current price of MXN589.24 — trading 14.9% below its estimated fair value. The current Tax Provision is MXN458 Mil. Hims & Hers Health's overall GF Score™ is 58/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tax Provision calculated?
Tax Provision is calculated from a company's financial statements. For Hims & Hers Health (MEX:HIMS), the current Tax Provision is MXN458 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hims & Hers Health (MEX:HIMS) Overvalued in 2026?

Based on GuruFocus' analysis, Hims & Hers Health stock appears to be undervalued. The current stock price of MXN589.24 is trading 14.9% below its estimated GF Value™ of MXN692.64. GuruFocus considers Hims & Hers Health to be Modestly Undervalued.

Key valuation signals for MEX:HIMS:

  • Tax Provision: MXN458 Mil
  • GF Value™: MXN692.64 vs. price of MXN589.24 (14.9% below fair value)
  • GF Score™: 58/100 with 3 warning signs

No single metric tells the full story. See the MEX:HIMS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Hims & Hers Health Business Description

Other Exchanges HIMS:USA82W:Germany
Address 2269 Chestnut Street, No. 523, San Francisco, CA, USA, 94123
Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.
58GF Score

Get the complete analysis for MEX:HIMS

Tax Provision is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN589.24
Price
MXN692.64
GF Value